z-logo
open-access-imgOpen Access
Global analysis of A-to-I RNA editing reveals association with common disease variants
Author(s) -
Oscar Franzén,
Raili Ermel,
Katyayani Sukhavasi,
Rajeev Jain,
Anamika Jain,
Christer Betsholtz,
Chiara Giannarelli,
Jason C. Kovacic,
Arno Ruusalepp,
Josefin Skogsberg,
Ke Hao,
Eric E. Schadt,
Johan Björkegren
Publication year - 2018
Publication title -
peerj
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.927
H-Index - 70
ISSN - 2167-8359
DOI - 10.7717/peerj.4466
Subject(s) - rna editing , rna , genome editing , inosine , biology , genetics , guide rna , computational biology , gene , crispr , adenosine , biochemistry
RNA editing modifies transcripts and may alter their regulation or function. In humans, the most common modification is adenosine to inosine (A-to-I). We examined the global characteristics of RNA editing in 4,301 human tissue samples. More than 1.6 million A-to-I edits were identified in 62% of all protein-coding transcripts. mRNA recoding was extremely rare; only 11 novel recoding sites were uncovered. Thirty single nucleotide polymorphisms from genome-wide association studies were associated with RNA editing; one that influences type 2 diabetes ( rs2028299 ) was associated with editing in ARPIN . Twenty-five genes, including LRP11 and PLIN5, had editing sites that were associated with plasma lipid levels. Our findings provide new insights into the genetic regulation of RNA editing and establish a rich catalogue for further exploration of this process.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom